Delivery Order SPE2DB20D2104-SPE2DB21FT55J

Award Date 8/4/21
Potential Completion Date 8/5/21
Potential Value $2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VASCEPA 1 GM CAPSULE 120S, a cardiovascular medication. The $7,777.43 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,755.84 firm fixed-price delivery order is for the supply of VASCEPA 1 GM CAPSULE 120S, a cardiovascular medication. The contract has a completion date of December 6, 2022 and was awarded on December 5, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $32,821.65 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of VASCEPA 1 GM CAPSULE 120S. This contract has a completion date of May 4, 2023 and uses a firm fixed price pricing type. The award was made without any set-aside designations, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $2,031.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of VASCEPA 1 GM CAPSULE 120S. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by AmerisourceBergen's parent company, Cencora, Inc. This IDC with the DLA Troop Support Medical serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,619.58 firm fixed-price delivery order is for the supply of Vascepa 1 GM capsules. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Vascepa 1 GM Capsule 120S, a prescription medication. The $17,517.47 Firm Fixed Price contract has an ultimate completion date of October 25, 2021. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VASCEPA 1 GM CAPSULE 120S. The $37,637.86 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,914.94, is for the delivery of VASCEPA 1 GM CAPSULE 120S, a cardiovascular medication, to support military healthcare programs. The contract has a completion date of December 6, 2023 and utilizes a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a subsidiary of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VASCEPA 1 GM CAPSULE 120S. The $2,214.48 Firm Fixed Price delivery order is a part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., which operates under the Amerisourcebergen brand. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VASCEPA 1 GM CAPSULE 120S. The $1,519.81 firm fixed-price delivery order was awarded on December 3, 2021, with a completion date of December 6, 2021. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB21FT55J
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,996.49 delivery order is for VASCEPA 1 GM CAPSULE 120S, a pharmaceutical product, under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition. In addition to the DLA contract, Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 2/27/25, 12:17 PM